Literature DB >> 17918377

Chemical inactivation of Toxoplasma gondii oocysts in water.

Katlyn E Wainwright1, Melissa A Miller, Bradd C Barr, Ian A Gardner, Ann C Melli, Tim Essert, Andrea E Packham, Tin Truong, Manuel Lagunas-Solar, Patricia A Conrad.   

Abstract

The protozoan parasite Toxoplasma gondii is increasingly recognized as a waterborne pathogen. Infection can be acquired by drinking contaminated water and conventional water treatments may not effectively inactivate tough, environmentally resistant oocysts. The present study was performed to assess the efficacy of 2 commonly used chemicals, sodium hypochlorite and ozone, to inactivate T. gondii oocysts in water. Oocysts were exposed to 100 mg/L of chlorine for 30 min, or for 2, 4, 8, 16, and 24 hr, or to 6 mg/L of ozone for 1, 2, 4, 8, or 12 min. Oocyst viability was determined by mouse bioassay. Serology, immunohistochemistry, and in vitro parasite isolation were used to evaluate mice for infection. Initially, mouse bioassay experiments were conducted to compare the analytical sensitivity of these 3 detection methods prior to completing the chemical inactivation experiments. Toxoplasma gondii infection was confirmed by at least 1 of the 3 detection methods in mice inoculated with all doses (10(5)-10(0)) of oocysts. Results of the chemical exposure experiments indicate that neither sodium hypochlorite nor ozone effectively inactivate T. gondii oocysts, even when used at high concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17918377     DOI: 10.1645/GE-1063R.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  27 in total

Review 1.  Interaction forces drive the environmental transmission of pathogenic protozoa.

Authors:  Aurélien Dumètre; Dominique Aubert; Pierre-Henri Puech; Jeanne Hohweyer; Nadine Azas; Isabelle Villena
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

2.  Determining UV inactivation of Toxoplasma gondii oocysts by using cell culture and a mouse bioassay.

Authors:  Michael W Ware; Swinburne A J Augustine; David O Erisman; Mary Jean See; Larry Wymer; Samuel L Hayes; J P Dubey; Eric N Villegas
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

3.  Physical inactivation of Toxoplasma gondii oocysts in water.

Authors:  Katlyn E Wainwright; Manuel Lagunas-Solar; Melissa A Miller; Bradd C Barr; Ian A Gardner; Cecilia Pina; Ann C Melli; Andrea E Packham; Nolan Zeng; Tin Truong; Patricia A Conrad
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

4.  Surface properties of Toxoplasma gondii oocysts and surrogate microspheres.

Authors:  Karen Shapiro; John Largier; Jonna A K Mazet; William Bernt; John R Ell; Ann C Melli; Patricia A Conrad
Journal:  Appl Environ Microbiol       Date:  2008-12-05       Impact factor: 4.792

Review 5.  Toxoplasma Effectors Targeting Host Signaling and Transcription.

Authors:  Mohamed-Ali Hakimi; Philipp Olias; L David Sibley
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 6.  A review on inactivation methods of Toxoplasma gondii in foods.

Authors:  Adel Mirza Alizadeh; Sahar Jazaeri; Bahar Shemshadi; Fataneh Hashempour-Baltork; Zahra Sarlak; Zahra Pilevar; Hedayat Hosseini
Journal:  Pathog Glob Health       Date:  2018-10-22       Impact factor: 2.894

Review 7.  Inactivation of exogenous endoparasite stages by chemical disinfectants: current state and perspectives.

Authors:  Arwid Daugschies; Berit Bangoura; Matthias Lendner
Journal:  Parasitol Res       Date:  2013-02-08       Impact factor: 2.289

8.  Methods to produce and safely work with large numbers of Toxoplasma gondii oocysts and bradyzoite cysts.

Authors:  H Fritz; B Barr; A Packham; A Melli; P A Conrad
Journal:  J Microbiol Methods       Date:  2011-10-20       Impact factor: 2.363

9.  Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.

Authors:  Joachim Müller; Adriana Aguado-Martínez; Luis-Miguel Ortega-Mora; Javier Moreno-Gonzalo; Ignacio Ferre; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Lynn K Barrett; Dustin J Maly; Kayode K Ojo; Wes Van Voorhis; Andrew Hemphill
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

Review 10.  Molecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interface.

Authors:  Elizabeth VanWormer; Heather Fritz; Karen Shapiro; Jonna A K Mazet; Patricia A Conrad
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-12-04       Impact factor: 2.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.